Cargando…
Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
BACKGROUND AND PURPOSE: Reduction of respiratory tumour motion is important in liver stereotactic body radiation therapy (SBRT) to reduce side effects and improve tumour control probability. We have assessed the distribution of use of voluntary exhale breath hold (EBH), abdominal compression (AC), f...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841271/ https://www.ncbi.nlm.nih.gov/pubmed/36655214 http://dx.doi.org/10.1016/j.phro.2022.12.004 |
_version_ | 1784869795691233280 |
---|---|
author | Hardcastle, Nicholas Gaudreault, Mathieu Yeo, Adam U. Ungureanu, Elena Markham, Cathy Barnes, Rebecca Chander, Sarat Chu, Julie |
author_facet | Hardcastle, Nicholas Gaudreault, Mathieu Yeo, Adam U. Ungureanu, Elena Markham, Cathy Barnes, Rebecca Chander, Sarat Chu, Julie |
author_sort | Hardcastle, Nicholas |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Reduction of respiratory tumour motion is important in liver stereotactic body radiation therapy (SBRT) to reduce side effects and improve tumour control probability. We have assessed the distribution of use of voluntary exhale breath hold (EBH), abdominal compression (AC), free breathing gating (gating) and free breathing (FB), and the impact of these on treatment time. MATERIALS AND METHODS: We assessed all patients treated in a single institution with liver SBRT between September 2017 and September 2021. Data from pre-simulation motion management assessment using fluoroscopic assessment of liver dome position in repeat breath holds, and motion with and without AC, was reviewed to determine liver dome position consistency in EBH and the impact of AC on motion. Treatment time was assessed for all fractions as time from first image acquisition to last treatment beam off. RESULTS: Of 136 patients treated with 145 courses of liver SBRT, 68 % were treated in EBH, 20 % with AC, 7 % in gating and 5 % in FB. AC resulted in motion reduction < 1 mm in 9/26 patients assessed. Median treatment time was higher using EBH (39 min) or gating (42 min) compared with AC (30 min) or FB (24 min) treatments. CONCLUSIONS: Motion management in liver SBRT needs to be assessed per-patient to ensure appropriate techniques are applied. Motion management significantly impacts treatment time therefore patient comfort must also be taken into account when selecting the technique for each patient. |
format | Online Article Text |
id | pubmed-9841271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98412712023-01-17 Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time Hardcastle, Nicholas Gaudreault, Mathieu Yeo, Adam U. Ungureanu, Elena Markham, Cathy Barnes, Rebecca Chander, Sarat Chu, Julie Phys Imaging Radiat Oncol Original Research Article BACKGROUND AND PURPOSE: Reduction of respiratory tumour motion is important in liver stereotactic body radiation therapy (SBRT) to reduce side effects and improve tumour control probability. We have assessed the distribution of use of voluntary exhale breath hold (EBH), abdominal compression (AC), free breathing gating (gating) and free breathing (FB), and the impact of these on treatment time. MATERIALS AND METHODS: We assessed all patients treated in a single institution with liver SBRT between September 2017 and September 2021. Data from pre-simulation motion management assessment using fluoroscopic assessment of liver dome position in repeat breath holds, and motion with and without AC, was reviewed to determine liver dome position consistency in EBH and the impact of AC on motion. Treatment time was assessed for all fractions as time from first image acquisition to last treatment beam off. RESULTS: Of 136 patients treated with 145 courses of liver SBRT, 68 % were treated in EBH, 20 % with AC, 7 % in gating and 5 % in FB. AC resulted in motion reduction < 1 mm in 9/26 patients assessed. Median treatment time was higher using EBH (39 min) or gating (42 min) compared with AC (30 min) or FB (24 min) treatments. CONCLUSIONS: Motion management in liver SBRT needs to be assessed per-patient to ensure appropriate techniques are applied. Motion management significantly impacts treatment time therefore patient comfort must also be taken into account when selecting the technique for each patient. Elsevier 2023-01-04 /pmc/articles/PMC9841271/ /pubmed/36655214 http://dx.doi.org/10.1016/j.phro.2022.12.004 Text en © 2022 Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Article Hardcastle, Nicholas Gaudreault, Mathieu Yeo, Adam U. Ungureanu, Elena Markham, Cathy Barnes, Rebecca Chander, Sarat Chu, Julie Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time |
title | Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time |
title_full | Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time |
title_fullStr | Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time |
title_full_unstemmed | Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time |
title_short | Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time |
title_sort | selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841271/ https://www.ncbi.nlm.nih.gov/pubmed/36655214 http://dx.doi.org/10.1016/j.phro.2022.12.004 |
work_keys_str_mv | AT hardcastlenicholas selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime AT gaudreaultmathieu selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime AT yeoadamu selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime AT ungureanuelena selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime AT markhamcathy selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime AT barnesrebecca selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime AT chandersarat selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime AT chujulie selectionofmotionmanagementinliverstereotacticbodyradiotherapyanditsimpactontreatmenttime |